Literature DB >> 16940103

Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipain.

Hua Xie1, Natalya I Belogortseva, Jie Wu, Wei-Hong Lai, Chin-ho Chen.   

Abstract

Human immunodeficiency virus (HIV) transmission through saliva is extremely low. Several oral components, including secretory immunoglobulin A and secretory leukocyte protease inhibitor, are known as potential inhibitory agents of HIV oral transmission. Here we examined anti-HIV activity of oral bacterial components. We showed that recombinant protein HGP44 derived from Porphyromonas gingivalis, one of the primary infectious agents of periodontitis, was capable of inhibiting HIV type 1 (HIV-1) replication. HGP44 bound specifically to HIV-1 gp120 and blocked HIV-1 envelope-mediated membrane fusion. These findings suggest that HGP44 of P. gingivalis can inhibit HIV-1 infection by blocking HIV-1 entry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940103      PMCID: PMC1563519          DOI: 10.1128/AAC.01578-05

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells.

Authors:  Y Kitamura; S Matono; Y Aida; T Hirofuji; K Maeda
Journal:  J Periodontal Res       Date:  2002-12       Impact factor: 4.419

3.  Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.

Authors:  H Chiba; J Inokoshi; M Okamoto; S Asanuma; M Iwama; K Mizumoto; H Tanaka; M Oheda; K Fujita; H Nakashima; M Shinose; Y Takahashi; S Omura
Journal:  Biochem Biophys Res Commun       Date:  2001-03-30       Impact factor: 3.575

4.  Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: a 2-year follow-up study.

Authors:  L Mellanen; T Sorsa; J Lähdevirta; M Helenius; K Kari; J H Meurman
Journal:  J Oral Pathol Med       Date:  2001-10       Impact factor: 4.253

5.  Porphyromonas gingivalis gingipains and adhesion to epithelial cells.

Authors:  T Chen; K Nakayama; L Belliveau; M J Duncan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Specific microbial colonizations in the periodontal sites of HIV-infected subjects.

Authors:  B R Chattin; K Ishihara; K Okuda; Y Hirai; T Ishikawa
Journal:  Microbiol Immunol       Date:  1999       Impact factor: 1.955

7.  Periodontopathic bacteria in English HIV-seropositive persons.

Authors:  C Scully; S R Porter; S Mutlu; J B Epstein; S Glover; N Kumar
Journal:  AIDS Patient Care STDS       Date:  1999-06       Impact factor: 5.078

8.  Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564.

Authors:  S L Holz-Smith; I C Sun; L Jin; T J Matthews; K H Lee; C H Chen
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva.

Authors:  D C Shugars; L L Patton; S A Freel; L R Gray; R T Vollmer; J J Eron; S A Fiscus
Journal:  J Dent Res       Date:  2001-02       Impact factor: 6.116

10.  Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis.

Authors:  L A Ximénez-Fyvie; A D Haffajee; S S Socransky
Journal:  J Clin Periodontol       Date:  2000-10       Impact factor: 8.728

View more
  7 in total

Review 1.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 2.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

3.  Porphyromonas gingivalis-mediated Epithelial Cell Entry of HIV-1.

Authors:  C K Mantri; C Chen; X Dong; J S Goodwin; H Xie
Journal:  J Dent Res       Date:  2014-05-29       Impact factor: 6.116

4.  Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells.

Authors:  Rodrigo A Giacaman; Anil C Asrani; Kristin H Gebhard; Elizabeth A Dietrich; Anjalee Vacharaksa; Karen F Ross; Mark C Herzberg
Journal:  Retrovirology       Date:  2008-03-27       Impact factor: 4.602

5.  Porphyromonas gingivalis short fimbriae are regulated by a FimS/FimR two-component system.

Authors:  Jie Wu; Xinghua Lin; Hua Xie
Journal:  FEMS Microbiol Lett       Date:  2007-04-20       Impact factor: 2.742

6.  Heat-stable molecule derived from Streptococcus cristatus induces APOBEC3 expression and inhibits HIV-1 replication.

Authors:  Ziqing Wang; Yi Luo; Qiujia Shao; Ballington L Kinlock; Chenliang Wang; James E K Hildreth; Hua Xie; Bindong Liu
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

7.  Role of Porphyromonas gingivalis outer membrane vesicles in oral mucosal transmission of HIV.

Authors:  Xin-Hong Dong; Meng-Hsuan Ho; Bindong Liu; James Hildreth; Chandravanu Dash; J Shawn Goodwin; Muthukumar Balasubramaniam; Chin-Ho Chen; Hua Xie
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.